ACADIA Pharmaceuticals Issues Earnings Results
| ASIMX Fund | USD 15.33 0.01 0.07% |
Slightly above 55% of Alger Smidcap's investor base is interested to short. The analysis of overall sentiment of trading Alger Smidcap Focus mutual fund suggests that many investors are impartial at this time. Alger Smidcap's investing sentiment can be driven by a variety of factors including economic data, Alger Smidcap's earnings reports, geopolitical events, and overall market trends.
Alger |
ACADIA Pharmaceuticals issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported 0.20 earnings per share for the quarter, topping analysts consensus estimates of 0.14 by 0.06, Briefing.com reports. The business had revenue of 250.40 million during the quarter, compared to the consensus estimate of 248.83 million. ACADIA
Read at thelincolnianonline.com
 |
Alger Smidcap Fundamental Analysis
We analyze Alger Smidcap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alger Smidcap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alger Smidcap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Alger Smidcap is currently under evaluation in price to book among similar funds. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Alger Smidcap Focus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alger Smidcap mutual fund to make a market-neutral strategy. Peer analysis of Alger Smidcap could also be used in its relative valuation, which is a method of valuing Alger Smidcap by comparing valuation metrics with similar companies.
Peers
Alger Smidcap Related Equities
| BIPIX | Biotechnology Ultrasector | 1.86 | ||||
| RYCFX | Biotechnology Fund | 1.22 | ||||
| USSCX | Science Technology | 0.71 | ||||
| JAGTX | Janus Global | 1.07 | ||||
| GISTX | Goldman Sachs | 1.20 | ||||
| GITAX | Goldman Sachs | 1.20 | ||||
| HTECX | Hennessy Technology | 1.20 | ||||
| PGKCX | Pgim Jennison | 1.51 |
Other Information on Investing in Alger Mutual Fund
Alger Smidcap financial ratios help investors to determine whether Alger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alger with respect to the benefits of owning Alger Smidcap security.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |